GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (OTCPK:CSPHF) » Definitions » Pretax Margin %

CStone Pharmaceuticals (CStone Pharmaceuticals) Pretax Margin % : -80.02% (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is CStone Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. CStone Pharmaceuticals's Pre-Tax Income for the six months ended in Jun. 2023 was $-29.22 Mil. CStone Pharmaceuticals's Revenue for the six months ended in Jun. 2023 was $36.51 Mil. Therefore, CStone Pharmaceuticals's pretax margin for the quarter that ended in Jun. 2023 was -80.02%.

The historical rank and industry rank for CStone Pharmaceuticals's Pretax Margin % or its related term are showing as below:

CSPHF' s Pretax Margin % Range Over the Past 10 Years
Min: -787.84   Med: -152.54   Max: -79.17
Current: -156.83


CSPHF's Pretax Margin % is ranked worse than
50.34% of 1027 companies
in the Biotechnology industry
Industry Median: -155.32 vs CSPHF: -156.83

CStone Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for CStone Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Pretax Margin % Chart

CStone Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial - -117.54 -787.85 -187.53 -79.17

CStone Pharmaceuticals Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -697.78 -138.13 -246.41 -80.02 -

Competitive Comparison of CStone Pharmaceuticals's Pretax Margin %

For the Biotechnology subindustry, CStone Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CStone Pharmaceuticals's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where CStone Pharmaceuticals's Pretax Margin % falls into.



CStone Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

CStone Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-51.432/64.962
=-79.17 %

CStone Pharmaceuticals's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-29.216/36.512
=-80.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CStone Pharmaceuticals  (OTCPK:CSPHF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


CStone Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CStone Pharmaceuticals (CStone Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123
CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (CStone Pharmaceuticals) Headlines

From GuruFocus